← All trials
NCT03102606
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 13, 2017
- Primary completion
- Mar 15, 2018
- Completion date
- Jun 15, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 170
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- BeyondSpring Pharmaceuticals Inc.Lead sponsor
- ICONCollaborator
- Stanford UniversityOverall official - principal investigator
- Chiltern InternationalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.